RocketTickers

RocketTickers

SRNE: Sorrento Therapeutics, Inc. 2021-04-27 11:39:47 Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 Antibody, for Advanced Urothelial Carcinoma

RocketTickers

ANAB: AnaptysBio, Inc. 2021-04-22 16:12:09 FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer

RocketTickers

RDNT: RadNet, Inc. 2021-04-19 06:00:00 RadNet’s Artificial Intelligence Subsidiary, DeepHealth, Announces FDA Clearance for its AI Mammography Triage Software

RocketTickers

MYOV,PFE: Myovant Sciences, Inc. 2021-03-24 06:30:00 Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids

RocketTickers

INSP: Inspire Medical Systems, Inc. 2021-03-15 16:05:00 Inspire Medical Systems, Inc. Announces FDA Approval of Two-Incision Implant Procedure

RocketTickers

SCYX: Scynexis 2021-03-02 07:30:00 SCYNEXIS Announces Positive Results from Interim Analyses of Ongoing Phase 3 Studies (FURI and CARES), Demonstrating Oral Ibrexafungerp's Ability to Treat Severe Fungal Infections in the Hospital Setting

RocketTickers

ALT: Altimmune, Inc. 2021-02-17 07:02:00 Altimmune Announces FDA Clearance of AdCOVID™ IND Application

RocketTickers

ADMA: ADMA Biologics, Inc. 2021-02-01 08:00:00 ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN

RocketTickers

SRNE: Sorrento Therapeutics, Inc. 2021-01-26 19:09:38 Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients

RocketTickers

MYOV,PFE: Myovant Sciences, Inc. 2021-01-26 06:55:00 Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis

RocketTickers

MYOV,PFE: Myovant Sciences, Inc. 2021-01-26 06:55:00 Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis

RocketTickers

HALO: Halozyme Therapeutics, Inc. 2021-01-15 17:00:00 Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis

RocketTickers

MYOV: Myovant Sciences, Inc. 2020-12-18 16:49:37 Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

RocketTickers

KPTI: Karyopharm Therapeutics Inc. 2020-12-18 11:30:00 Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy

RocketTickers

GSK: GlaxoSmithKline (GSK) 2020-12-17 08:59:00 FDA approves GSK's BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US

RocketTickers

ZLAB,MGNX: Zai Lab Limited 2020-12-16 20:15:08 Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer

RocketTickers

TGTX: TG Therapeutics, Inc. 2020-12-10 07:11:33 TG Therapeutics Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple Sclerosis

RocketTickers

CRIS: Curis, Inc. 2020-12-08 07:00:00 Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes